Michael Schneidman

1.1k total citations
21 papers, 823 citations indexed

About

Michael Schneidman is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Michael Schneidman has authored 21 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 3 papers in Pharmacology. Recurrent topics in Michael Schneidman's work include Schizophrenia research and treatment (15 papers), Obsessive-Compulsive Spectrum Disorders (5 papers) and Electroconvulsive Therapy Studies (5 papers). Michael Schneidman is often cited by papers focused on Schizophrenia research and treatment (15 papers), Obsessive-Compulsive Spectrum Disorders (5 papers) and Electroconvulsive Therapy Studies (5 papers). Michael Schneidman collaborates with scholars based in Israel, United Kingdom and Austria. Michael Schneidman's co-authors include Michael Poyurovsky, Abraham Weizman, Camil Fuchs, Ronit Weizman, Ilan Modai, Boris Rauchverger, Sarit Faragian, Victoria Isakov, Rivka Rockah and Artashes Pashinian and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Molecular Psychiatry.

In The Last Decade

Michael Schneidman

21 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Schneidman Israel 13 549 320 188 164 129 21 823
Reid Robison United States 16 319 0.6× 203 0.6× 249 1.3× 113 0.7× 141 1.1× 37 811
M.-C. Bourdel France 15 280 0.5× 247 0.8× 270 1.4× 185 1.1× 222 1.7× 29 891
Pascale Mazzola‐Pomietto France 18 382 0.7× 192 0.6× 265 1.4× 60 0.4× 221 1.7× 33 837
Françoise Biver Belgium 11 197 0.4× 196 0.6× 312 1.7× 157 1.0× 239 1.9× 18 825
Sarit Faragian Israel 16 353 0.6× 428 1.3× 300 1.6× 90 0.5× 37 0.3× 20 699
Colin Bouwer South Africa 18 217 0.4× 484 1.5× 179 1.0× 124 0.8× 78 0.6× 22 895
Arantzazu Zabala Spain 19 549 1.0× 118 0.4× 232 1.2× 67 0.4× 55 0.4× 26 781
Isabel Martínez‐Gras Spain 15 277 0.5× 94 0.3× 146 0.8× 132 0.8× 175 1.4× 35 725
H.‐G. Weijers Germany 14 309 0.6× 176 0.6× 321 1.7× 31 0.2× 231 1.8× 18 853
F. Müller-Siecheneder Germany 11 316 0.6× 93 0.3× 188 1.0× 144 0.9× 103 0.8× 17 772

Countries citing papers authored by Michael Schneidman

Since Specialization
Citations

This map shows the geographic impact of Michael Schneidman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schneidman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schneidman more than expected).

Fields of papers citing papers by Michael Schneidman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schneidman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schneidman. The network helps show where Michael Schneidman may publish in the future.

Co-authorship network of co-authors of Michael Schneidman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schneidman. A scholar is included among the top collaborators of Michael Schneidman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schneidman. Michael Schneidman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poyurovsky, Michael, Sarit Faragian, Michael Schneidman, et al.. (2005). Familial aggregation of schizophrenia‐spectrum disorders and obsessive‐compulsive associated disorders in schizophrenia probands with and without OCD. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 133B(1). 31–36. 38 indexed citations
2.
Schneidman, Michael, et al.. (2003). System flexibility in the rehabilitation process of mentally disabled persons in a hostel that bridges between the hospital and the community.. PubMed. 40(4). 274–82. 2 indexed citations
3.
Poyurovsky, Michael, Camil Fuchs, Michael Schneidman, et al.. (2003). Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study. American Journal of Psychiatry. 160(2). 297–302. 103 indexed citations
4.
Poyurovsky, Michael, et al.. (2003). Efficacy of Low-Dose Mirtazapine in Neuroleptic-Induced Akathisia: A Double-Blind Randomized Placebo-Controlled Pilot Study. Journal of Clinical Psychopharmacology. 23(3). 305–308. 44 indexed citations
5.
Poyurovsky, Michael, Sarit Faragian, Rena Kurs, et al.. (2003). Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. 64(11). 1300–1307. 53 indexed citations
6.
Poyurovsky, Michael, Artashes Pashinian, Irit Gil‐Ad, et al.. (2002). Olanzapine-Induced Weight Gain in Patients With First-Episode Schizophrenia: A Double-Blind, Placebo-Controlled Study of Fluoxetine Addition. American Journal of Psychiatry. 159(6). 1058–1060. 81 indexed citations
7.
Fuchs, Camil, et al.. (2002). Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: A double-blind randomized placebo-controlled pilot study. European Neuropsychopharmacology. 12. 300–300. 1 indexed citations
8.
Poyurovsky, Michael, et al.. (2002). [Adherence to antipsychotic medication in schizophrenia patients].. PubMed. 141(12). 1042–9, 1090. 6 indexed citations
9.
Poyurovsky, Michael, Victoria Isakov, Boris Rauchverger, et al.. (2001). Obsessive–compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Research. 102(1). 49–57. 119 indexed citations
10.
Schneidman, Michael, et al.. (2001). Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.. PubMed. 62 Suppl 2. 28–34. 26 indexed citations
11.
Dossenbach, Martín, Robert H. Belmaker, Avner Elizur, et al.. (2000). The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine. Clinical Therapeutics. 22(9). 1021–1034. 39 indexed citations
12.
Poyurovsky, Michael, Rachel Nave, Rachel Epstein, et al.. (2000). Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia. European Neuropsychopharmacology. 10(3). 171–176. 35 indexed citations
13.
Poyurovsky, Michael, et al.. (1999). Treatment of neuroleptic-induced akathisia with the 5-HT2antagonist mianserin. The British Journal of Psychiatry. 174(3). 238–242. 53 indexed citations
14.
Poyurovsky, Michael, et al.. (1999). Fluvoxamine treatment of obsessivecompulsive symptoms in schizophrenic patients: an add-on open study. International Clinical Psychopharmacology. 14(2). 95–100. 39 indexed citations
15.
Frisch, Amos, Rivka Rockah, Elena Michaelovsky, et al.. (1999). Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Molecular Psychiatry. 4(4). 389–392. 151 indexed citations
16.
Wimmer, Peter, et al.. (1998). Treatment failure with risperidone: Can olanzapine be an alternative therapy?. Schizophrenia Research. 29(1-2). 148–148. 2 indexed citations
17.
Poyurovsky, Michael, et al.. (1998). Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.. PubMed. 21(2). 97–100. 17 indexed citations
18.
Poyurovsky, Michael, Michael Schneidman, & Abraham Weizman. (1997). Successful treatment of fluoxetine‐indueed dystonia with low‐dose mianserin. Movement Disorders. 12(6). 1102–1105. 4 indexed citations
19.
Schneidman, Michael, et al.. (1995). Verapamil treatment in clozapine-induced sleep-related enuresis: a case report. European Psychiatry. 10(8). 413–415. 2 indexed citations
20.
Poyurovsky, Michael, et al.. (1995). Akathisia-like behavior following ECT, and its successful treatment with low-close mianserin. International Clinical Psychopharmacology. 10(4). 257–260. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reid Robison Breakdown of academic impact, for papers by M.-C. Bourdel Breakdown of academic impact, for papers by Pascale Mazzola‐Pomietto Breakdown of academic impact, for papers by Françoise Biver Breakdown of academic impact, for papers by Sarit Faragian Breakdown of academic impact, for papers by Colin Bouwer Breakdown of academic impact, for papers by Arantzazu Zabala Breakdown of academic impact, for papers by Isabel Martínez‐Gras Breakdown of academic impact, for papers by H.‐G. Weijers Breakdown of academic impact, for papers by F. Müller-Siecheneder
Rankless by CCL
2026